Grey Street Capital’s Elanco Animal Health ELAN Stock Holding History

Grey Street Capital’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,011	Closed	-$121K	–	131
2023 Q2	$121K	Sell	12,011 -211	-2%	-$1.96K	0.06%	125
2023 Q1	$115K	Buy	+12,222	New	+$144K	0.08%	121

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Grey Street Capital's ELAN Position: Q3 2023 in Review

Grey Street Capital sold out of Elanco Animal Health (ELAN) in Q3 2023, closing a stake of 12,011 shares — an estimated $121K sold.

Grey Street Capital first reported a position in ELAN in Q1 2023 and held it in 2 quarters. The position peaked at $121K in Q2 2023. 350 funds tracked by Wall St. Rank hold ELAN as of Q3 2023.

Grey Street Capital reported no remaining Elanco Animal Health position as of Q3 2023 after selling out during the quarter.
Grey Street Capital sold 12,011 Elanco Animal Health shares in Q3 2023, an estimated $121K.
Grey Street Capital first reported a position in Elanco Animal Health in Q1 2023 and held it in 2 quarters.
Grey Street Capital's Elanco Animal Health position peaked at $121K in Q2 2023.
350 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2023.

Based on Grey Street Capital's 13F filing for Q3 2023, filed 11 Oct 2023.